Ozempic and Wegovy officially moved off FDA’s drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...
Ricezempic: Is this viral weight loss trend safe?
From lemon coffee to oatzempic, there's always a new weight loss hack people are buzzing about. The latest of these is ricezempic. It's a limey drink of rice water, and hundreds of TikTok users are ...
Why Hims & Hers Health Stock Is Plummeting Today
Hims & Hers, one of the most popular telehealth services in the world, is in danger of losing one of its central revenue sources. The U.S. Food and Drug Administration (FDA) removed semaglutide ...
This Is Money on MSN40m
Should you turn to Europe and tuck into the Granola shares?
Novo Nordisk, the Danish pharmaceutical behemoth, is the maker of the anti-obesity drugs Ozempic and Wegovy. Novo Nordisk ...
It finally happened.
According to the FDA, there is no longer a shortage of semaglutide, the active ingredient in the wildly popular Ozempic and Wegovy — a very bad omen for the countless telehealth and pharmacy ...